A critical discovery in cancer research is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial cancer suppressor protein is frequently disabled in several kinds of malignancies, leading https://bookmarksusa.com/story22026208/nanobodies-reactivate-tumor-suppressor-p53-new-promising-hope-for-cancer-management